Bausch Health Companies Inc
Bausch Health Companies Inc/ CA0717341071 /
BHC
|
26/07/2024 22:10:00
|
Chg.
+0.11
|
Volume |
Bid02:00:00 |
Demandez à02:00:00 |
Capitalisation boursière |
Dividende Y. |
Rapport P/E |
|
5.99USD
|
+1.87%
|
5.18 Mio.
Chiffrre d'affaires: 28.23 Mio. |
5.40Bid taille: 200 |
6.00Ask la taille: 200 |
2.2 Mrd.USD |
- |
- |
Description de l'entreprise
Bausch Health Companies Inc. is a global company whose mission is to improve people's lives with health care products. Bausch develops, manufactures and markets a range of pharmaceutical, medical device and over-the-counter products, primarily in the therapeutic areas of eye health, gastroenterology and dermatology.
Conseil d'administration & Conseil de surveillance
| PDG |
| Thomas J. Appio |
| Conseil d'administration |
| Tom Vadaketh, Seana Carson, Mirza Dautbegovic, Kathleen Fitzpatrick, Jeff Hartness, Cees Heiman, Graham Jackson, Jiny Kim, Donald Pearl, Josh Coyle, Nicola Kayel, Dr. Tage Ramakrishna, M.D., Tom Stern, Fernando Zarate |
| Conseil de surveillance |
| John A. Paulson, Thomas J. Appio, Brett M. Icahn, Sarah B. Kavanagh, Steven D. Miller, Dr. Richard Mulligan, Robert N. Power, Russel C. Robertson, Thomas W. Ross, Sr., Amy B. Wechsler, M.D. |
Données de l'entreprise
| Nom: |
Bausch Health Companies Inc. |
| Adresse: |
2150 St. Elzéar Blvd. West,Laval, Quebec H7L 4A8, Canada |
| Téléphone: |
+1(800) 361-1448 |
| Fax: |
- |
| Courriel: |
-
|
| Internet: |
https://www.bauschhealth.com/ |
| Industrie: |
Healthcare |
| Secteur: |
Pharmaceutical Industry |
| Sous-secteur: |
Pharmaceuticals |
| Fin de l'exercice financier: |
31/12 |
| Flotte libre: |
- |
| IPO date: |
- |
Relations avec les investisseurs
| Nom: |
Arthur Shannon |
| Téléphone IR: |
+1-877-281-6642 |
| IR-Fax: |
- |
| E-mail IR: |
ir@bauschhealth.com
|
Calendrier de l'entreprise
|
CW 31 | 01/08/2024
Interim Report 2nd Quarter/6 Months
|
